Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
1,591
Value
$53.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RARE by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,591$53.1K<0.1%−724−31.3%ReducedHolders
Q1 20262,315$48.5K<0.1%+1,235+114.4%AddedHolders
Q4 20251,080$24.8K<0.1%−215−16.6%ReducedHolders
Q3 20251,295$39.0K<0.1%−1,535−54.2%ReducedHolders
Q2 20252,830$102.9K<0.1%−27−0.9%ReducedHolders
Q1 20252,857$103.5K<0.1%−677−19.2%ReducedHolders
Q4 20243,534$148.7K<0.1%−615−14.8%ReducedHolders
Q3 20244,149$230.5K<0.1%−2,916−41.3%ReducedHolders
Q2 20247,065$290.4K<0.1%−78−1.1%ReducedHolders
Q1 20247,143$333.5K<0.1%+390+5.8%AddedHolders
Q4 20236,753$322.9K<0.1%+227+3.5%AddedHolders
Q3 20236,526$232.7K<0.1%−663−9.2%ReducedHolders
Q2 20237,189$331.6K<0.1%+4,537+171.1%AddedHolders
Q1 20232,652$106.3K<0.1%−371−12.3%ReducedHolders
Q4 20223,023$140.1K<0.1%−5,458−64.4%ReducedHolders
Q3 20228,481$351.0K<0.1%+200+2.4%AddedHolders
Q2 20228,281$495.0K<0.1%−330−3.8%ReducedHolders
Q1 20228,611$625.0K<0.1%+1,097+14.6%AddedHolders
Q4 20217,514$631.0K<0.1%−8,965−54.4%ReducedHolders
Q3 202116,479$1.49M<0.1%+716+4.5%AddedHolders
Q2 202115,763$1.50M<0.1%−4,030−20.4%ReducedHolders
Q1 202119,793$2.25M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.